TYPHARM DEVELOPMENTS LIMITEDActive
Key figures
Like most small UK companies, TYPHARM DEVELOPMENTS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | — | — | 5,023,333 | 5,844 |
| Total assets | 2,185,452 | 2,167,746 | 2,261,469 | 11,679,225 | 16,107,226 |
| Total liabilities | 67,470 | 2,940 | 31,735 | 9,839 | 46,174 |
| Net assets / total equity | 1,906,902 | 1,970,447 | 2,057,055 | 11,525,776 | 15,912,117 |
| Average number of employees | 2 | 2 | 2 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: TYPHARM DEVELOPMENTS LIMITED
Company
TYPHARM DEVELOPMENTS LIMITED is a private limited company registered with Companies House under company number 08272004. It was incorporated on 29 Oct 2012. Its status is active. The registered office is in Norwich (NR13). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £15,912,117, up 38.1% on the previous year. Cash at bank and in hand was £5,844. Total assets were £16,107,226 and total liabilities £46,174. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 24 Mar 2027.